11:12 AM EDT, 08/21/2025 (MT Newswires) -- Shattuck Labs ( STTK ) said Thursday its Investigational New Drug application submitted to the US Food and Drug Administration for SL-325, a blocking antibody to treat inflammatory bowel disease, is in effect. SL-325 showed a favorable safety profile in non-human primate studies. Dosing of healthy volunteers in the company's randomized, double-blind, placebo-controlled...

(Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness. CVS based the decision on clinical, financial, and regulatory factors, spokesperson David Whitrap said in an email. It also will not cover Yeztugo under its...

11:09 AM EDT, 08/21/2025 (MT Newswires) -- (Updates with NHTSA's report throughout the story.) Tesla (TSLA) is facing a US National Highway Traffic Safety Administration's audit query over delays in reporting crashes that took place several months or more before the dates of the reports, the regulator said in a report. The Standing General Order in place at the time...

11:29 AM EDT, 08/21/2025 (MT Newswires) -- (Corrects story to denote President Donald Trump is the current president.) US Commerce Secretary Howard Lutnick is exploring the possibility of the federal government taking equity stakes in semiconductor companies that receive CHIPS Act funding to build factories in the US, Reuters reported Wednesday, citing sources. The idea expands on an existing plan...